Cel AI PLC (CLAI) - Net Assets
Based on the latest financial reports, Cel AI PLC (CLAI) has net assets worth GBX410.51K GBX (≈ $49.95 USD) as of February 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX468.87K ≈ $57.05 USD) and total liabilities (GBX58.36K ≈ $7.10 USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read Cel AI PLC (CLAI) financial obligations for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX410.51K |
| % of Total Assets | 87.55% |
| Annual Growth Rate | 56.15% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 82.31 |
Cel AI PLC - Net Assets Trend (2019–2024)
This chart illustrates how Cel AI PLC's net assets have evolved over time, based on quarterly financial data. Also explore Cel AI PLC asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for Cel AI PLC (2019–2024)
The table below shows the annual net assets of Cel AI PLC from 2019 to 2024. For live valuation and market cap data, see CLAI stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-08-31 | GBX514.55K ≈ $62.61 |
-77.26% |
| 2023-08-31 | GBX2.26 Million ≈ $275.32 |
-53.37% |
| 2022-08-31 | GBX4.85 Million ≈ $590.38 |
-54.00% |
| 2021-08-31 | GBX10.55 Million ≈ $1.28K |
+12771.65% |
| 2020-08-31 | GBX-83.24K ≈ $-10.13 |
-250.33% |
| 2019-08-31 | GBX55.37K ≈ $6.74 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Cel AI PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1343717600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (August 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX602.25K | 117.04% |
| Other Components | GBX13.43 Million | 2609.37% |
| Total Equity | GBX514.55K | 100.00% |
Cel AI PLC Competitors by Market Cap
The table below lists competitors of Cel AI PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
XTC Lithium Limited
AU:XTC
|
$87.64K |
|
NEW FRONTIER VENT. INC.
F:S1O
|
$87.70K |
|
Abacus Global Management, Inc.
NASDAQ:ABX
|
$88.19K |
|
Verici Dx Plc
LSE:VRCI
|
$88.39K |
|
Delta Electronics (Thailand) Public Company Limited
F:DLS
|
$87.45K |
|
Mondee Holdings Inc.
NASDAQ:MONDQ
|
$87.42K |
|
Sancus Lending Group Ltd
LSE:LEND
|
$87.04K |
|
Goldstone Resources Ltd
LSE:GRL
|
$86.62K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cel AI PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,262,808 to 514,554, a change of -1,748,254 (-77.3%).
- Net loss of 1,827,461 reduced equity.
- Other comprehensive income decreased equity by 1,713,067.
- Other factors increased equity by 1,792,274.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-1.83 Million | -355.15% |
| Other Comprehensive Income | GBX-1.71 Million | -332.92% |
| Other Changes | GBX1.79 Million | +348.32% |
| Total Change | GBX- | -77.26% |
Book Value vs Market Value Analysis
This analysis compares Cel AI PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 146.30x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 1139.45x to 146.30x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-08-31 | GBX0.00 | GBX0.13 | x |
| 2020-08-31 | GBX0.00 | GBX0.13 | x |
| 2021-08-31 | GBX0.02 | GBX0.13 | x |
| 2022-08-31 | GBX0.01 | GBX0.13 | x |
| 2023-08-31 | GBX0.00 | GBX0.13 | x |
| 2024-08-31 | GBX0.00 | GBX0.13 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cel AI PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -355.15%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -10185.38%
- • Asset Turnover: 0.03x
- • Equity Multiplier: 1.27x
- Recent ROE (-355.15%) is below the historical average (-132.62%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -139.29% | 0.00% | 0.00x | 1.47x | GBX-82.67K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | GBX-321.50K |
| 2021 | -31.60% | 0.00% | 0.00x | 1.02x | GBX-4.39 Million |
| 2022 | -123.39% | -20714.62% | 0.01x | 1.06x | GBX-6.47 Million |
| 2023 | -146.27% | -4922.54% | 0.03x | 1.08x | GBX-3.54 Million |
| 2024 | -355.15% | -10185.38% | 0.03x | 1.27x | GBX-1.88 Million |
Industry Comparison
This section compares Cel AI PLC's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,079,757,075
- Average return on equity (ROE) among peers: 16.06%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cel AI PLC (CLAI) | GBX410.51K | -139.29% | 0.14x | $87.49K |
| Creightons Plc (CRL) | $7.14 Million | 7.85% | 0.50x | $179.26K |
| McBride plc (MCB) | $51.40 Million | 32.30% | 4.90x | $3.30 Million |
| PZ Cussons PLC (PZC) | $359.40 Million | 11.80% | 0.50x | $3.93 Million |
| Revolution Beauty Group PLC (REVB) | $-17.06 Million | 0.00% | 0.00x | $368.25K |
| Reckitt Benckiser Group PLC (RKT) | $2.38 Billion | 39.33% | 1.46x | $386.42 Million |
| Unilever PLC (ULVR) | $5.76 Billion | 14.52% | 1.62x | $1.17 Billion |
| Venture Life Group PLC (VLG) | $75.66 Million | 0.69% | 0.66x | $837.60K |
| Warpaint London PLC (W7L) | $14.28 Million | 22.00% | 0.31x | $1.74 Million |
About Cel AI PLC
Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare products. The company was formerly known as Cellular Goods PLC and changed its name to Cel AI PLC in February 2024. Cel AI PLC was incorporated in 2018 and is based in London, United King… Read more